Cabrera RA, Castillo AJ, Santiago RA, Endonio JI, Gutiérrez CP, Romero RI, Laguna HG

Language: Spanish
References: 18
Page: 104-108
PDF size: 195.74 Kb.

ABSTRACT

Sepsis its complications are a major public health problem in the world. Tissue hypoperfusion as a result of peripheral vasodilatation, capillary leak syndrome, myocardial depression, activation of the coagulation cascade and release of proinflammatory cytokines are the basis for the development of multiple organ dysfunction and death. In this paper, the authors present an updated review of the pathophysiology, biomarkers and treatment focused attention on the Emergency Services.

REFERENCES

1. American College of Chest Physicians/ Society of Critical Care Medicine. Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864.

2. Levy MM, Fink MP, Marshall JC, et al: 2001 SCCM/ESICM/ ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31: 1250–1256.

3. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348: 1546-1554.

4. Cabrera RA, Laguna HG, López HG, Villagómez OA, Méndez RR, Guzmán GR. Mecanismos patogénicos en sepsis y choque séptico. Med Int Mex 2008; 24 (1): 38-42.

5. Bell K, Wattie M, Byth K et al. Procalcitonin: a marker of bacteriemia in SIRS. Anaesth Int Care 2003; 6: 629-36.

6. Brunkhorst FM, Heinz U, Forycki ZF. Kinetics of procalcitonin in iatrogenic sepsis. Int Care Med 1998; 24: 888-9.

7. De Kruif MD, Limper M, Gerritsen H, Spek CA et al. Crit Additional value of procalcitonin for diagnosis of infection in patients with fever at the Emergency Department. Care Med 2010; 38: 457-463.

8. Nguyen HB, Emanuel MS. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med 2004; 32 (8): 1637-42.

9. Porras-García W, Ige-Afuso M, Ormea-Villavicencio A. Depuración de lactato como indicador pronóstico de mortalidad en pacientes con sepsis severa y choque séptico. Rev Soc Peru Med Interna 2007; 20 (4): 132-138.

10. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M, the Early Goal-Directed Therapy Collaborative Group: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345: 1368-1377.

11. Finfer S, Bellomo R, Boyce N et al: A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004; 350: 2247-2256.

12. De Backer D, Creteur J, Silva E et al: Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: Which is best? Crit Care Med 2003; 31: 1659-1667.

13. Levy B, Bollaert PE, Luchelli JP, Sadoune LO. Dobutamine improves the adequacy of gastric mucosal perfusion in epinephrine- treated septic shock. Crit Care Med 1997; 25: 1649-1654.

14. Gattinoni L, Brazzi L, Pelosi P et al. A trial of goal-oriented hemodynamic therapy in critically ill patients. N Engl J Med 1995; 333: 1025-1032.

15. Annane D, Sebille V, Charpentier C et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288: 862-871.

16. Sprung CL, Annane D, Briegel J et al. Corticosteroid therapy of septic shock (CORTICUS). Abstr Am Rev Respir Crit Care Med 2007; 175: A507.

17. Bernard GR, Vincent JL, Laterre PF et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344: 699-709.

18. Kumar A, Roberts D, Wood KE et al. Duration of hypotension prior to initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34: 1589-1596.